[Federal Register: April 6, 2005 (Volume 70, Number 65)]
[Notices]
[Page 17472-17473]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06ap05-117]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in Schedule I or II and prior to issuing a
registration under 21 U.S.C. 952 (a) (2) (B) authorizing the
importation of such a substance, provide manufacturers holding
registrations for the bulk manufacture of the substance an opportunity
for a hearing.
Therefore, in accordance with 21 CFR 1301.34(a), this is notice
that on February 1, 2005, Penick Corporation, 158 Mount Olivet Avenue,
Newark, New Jersey 07114, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as an importer of the
basic classes of controlled substances listed in Schedules II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Coca Leaves (9040)......................... II
Raw Opium (9600)........................... II
Poppy Straw (9650)......................... II
Poppy Straw Concentrate (9670)............. II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacturer bulk controlled substances and non-controlled substance
flavor extracts.
Any manufacturer who is presently, or is applying to be, registered
with DEA
[[Page 17473]]
to manufacture such basic classes of controlled substances may file
comments or objections to the issuance of the proposed registration and
may, at the same time, file a written request for a hearing on such
application pursuant to 21 CFR 1301.43 and in such form as prescribed
by 21 CFR 1316.47.
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than May 6, 2005.
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1301.34(b), (c), (d),
(e) and (f). As noted in a previous notice published in the Federal
Register on September 23, 1975, (40 FR 43745-46), all applicants for
registration to import a basic class of any controlled substance listed
in Schedule I or II are, and will continue to be required to
demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for
such registration pursuant to 21 U.S.C. 958(a), 21 U.S.C. 823(a), and
21 CFR 1301.34(b), (c), (d), (e) and (f) are satisfied.
Dated: March 29, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-6786 Filed 4-5-05; 8:45 am]
BILLING CODE 4410-09-P